Intimation of investor meeting.

Board & Shareholder Meetings View source PDF

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Aurobindo Pharma has informed the stock exchanges that its officials will participate in an investor plant visit on June 24, 2025, from 11:30 AM to 3:00 PM IST. The meeting is being arranged by B&K Securities and will be held in Hyderabad in an in-person format. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during the interaction. The schedule may change due to unforeseen circumstances on either side.

Likely market impact

This is a routine disclosure about an investor engagement and is unlikely to have any direct impact on the stock price. Investors may watch the meeting for any informal commentary on the company's business outlook.